'Goldman Sachs analyst Mark Delaney raised the firm's price target on Tesla to $925 from $864 and keeps a Buy rating on the shares. The company's margin upside in Q1 illustrates its "good earnings potential," Delaney tells investors in a post-earnings research note. The report shows that Tesla is on pace to generate strong margins in the intermediate to longer-term, and in turn drive "material" earnings growth, contends the analyst. Delaney expects "weak" Q2 results given the continued shutdown of Tesla's Fremont factory related to COVID-19 restrictions in the region, but he sees good intermediate to longer-term revenue growth as electric vehicle adoption increases and due to the company's product leadership.'
'
JMP Securities analyst Joseph Osha raised the price target on
Tesla (NASDAQ:
TSLA) to $1,020.00 (from $840.00) while raising 2021 estimates slightly. The bulk of the move in price target is a shift in multiples to pre-COVID levels.
The analyst reiterated a Market Outperform rating, stating "As dim as the near-term picture is, TSLA’s long-term prospects are as bright as they have ever been. The company has the balance sheet to continue expanding, and as we expected, Mr. Musk reiterated his commitment to expansion on yesterday’s call". He went on to state "we are shifting to a 32x EV/EBITDA target from 25x, and a 5.5x EV/revenue target from 4x. The result supports a price target of $1,020, up from our previous $840 target".
'Credit Suisse analyst Dan Levy raised the firm's price target on Tesla to $700 from $580 following the company's "gross margin fueled beat" in Q1, which he believes should continue near-term momentum in the stock. In addition to "providing us with an interesting call," Elon Musk expressed confidence in 40% compound annual growth over the next 5-10 years and said capacity expansion plans are intact, leaving the central long-term narrative intact, Levy tells investors. Levy keeps a Neutral rating on Tesla shares as he expects some impact to the stock when it really gets confronted with coronavirus weakness via volume softness or greater cash burn.'